| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |